Ex parte FRASCOTTI et al. - Page 2




          Appeal No. 1996-1042                                                        
          Application No. 07/810,138                                                  


               Claims 9 and 14, which are illustrative of the subject                 
          matter on appeal, read as follows:                                          
               9.  A biologically pure culture of asporogenous strain                 
          Bacillus subtilis SMS275, suitable for use as a host component              
          in a host-vector system, characterized in that said stain                   
          [sic] has a frequency of reversion to spore formers of less                 
                 -8                                                -               
          than 10 , plasmid stability, genetic markers leu, pyrD1, apr ,              
          npr  and spoII:D [sic], and is deposited as CBS 432.90.-                                                                        
               14. A process for the production of a heterologous                     
          polypeptide or protein or a precursor thereof, comprising the               
          steps of:                                                                   
               a) transforming an asporogenous strain Bacillus subtilis               
          SMS275 with a plasmid vector containing a gene coding for a                 
          heterologous polypeptide or protein or a precursor thereof,                 
               wherein said asporogenous strain Bacillus subtilis SMS275              
          is characterized in that it has a frequency of reversion to                 
          spore formers of less than 10 , plasmid stability, genetic-8                                             
                                 -     -                                              
          markers leu, pyrD1, apr , npr  and spoII:D [sic], and is                    
          deposited as CBS 432.90;                                                    
               b) culturing the transformed asporogenous strain Bacillus              
          subtilis of step (a) in a suitable culture medium containing a              
          carbon source, a nitrogen source, mineral salts, leucine and                
          uracil; and                                                                 
               (c) recovering said heterologous polypeptide or protein                
          or a precursor thereof.                                                     
               The references relied on by the examiner are:                          
          Young et al. (Young)               4,302,544        Nov. 24, 1981           
          Dean et al. (Dean '235)            4,450,235        May  22, 1984           
          Dean et al. (Dean '236)            4,450,236        May  22, 1984           
          Dean et al. (Dean '773)            4,465,773        Aug. 14, 1984           
          Furutani et al. (Furutani)         5,015,574        May  14, 1991           

                                         -2-                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007